CreakyJoints & Yale Rheumatology Medication Decision SurveyCreakyJoints and Yale Rheumatology want to help patients with rheumatoid arthritis (RA) make the best decisions about treatment with their doctors’ help.

The objective of this study is to find out how patients think about the risks and benefits related to different treatment options. This information will be used to describe why different groups of patients choose different medications.

To participate in this study, you must:

  • be 18 years of age or older
  • have rheumatoid arthritis
  • currently take at least one disease-modifying anti-rheumatic drug or “DMARD” such as methotrexate, Arava, or a biologic.

This study involves answering an online survey on your computer or tablet (NOT your phone) that will take about 30 minutes or more.

Enter your email below and we’ll send you an invitation to take the survey. Thank you for helping patients like yourself make the best treatment decisions.

The principal investigator of this study is Dr. Liana Fraenkel, M.D., M.P.H., Yale School of Medicine. If you have any questions about the survey, please email us at [email protected]